AcquisitionOther
BioMarin Pharmaceutical acquired Amicus Therapeutics
Public deal record from 8-K. The source names the buyer and target, and terms are shown only when the filing or announcement discloses them.
Deal tape row
BioMarin Pharmaceutical -> Amicus Therapeutics · approximately $4.8 billion
To strengthen and diversify growth profile while advancing mission to deliver medicines for people living with rare diseases.
Open source record (SEC) ↗